Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma

SIMPLE SUMMARY: Among primary brain tumours, glioblastoma is the most aggressive. As early relapses are unavoidable despite standard-of-care treatment, the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) alone or in combination have been suggested as a combined treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lah, Tamara T., Novak, Metka, Pena Almidon, Milagros A., Marinelli, Oliviero, Žvar Baškovič, Barbara, Majc, Bernarda, Mlinar, Mateja, Bošnjak, Roman, Breznik, Barbara, Zomer, Roby, Nabissi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914500/
https://www.ncbi.nlm.nih.gov/pubmed/33562819
http://dx.doi.org/10.3390/cells10020340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914500/
https://www.ncbi.nlm.nih.gov/pubmed/33562819
http://dx.doi.org/10.3390/cells10020340

Ejemplares similares